Member Info for MIKODX

RE: Monday SP competition! 19 Jul 2020 22:15

On the 27th May this jumped from .50 to .91, but copped a speeding ticket for it. DF brought no reaction, so it could go either way in the morning. My guess is we could see .55 .60 tomorrow.

I wasn't too far wrong.

https://www.theguardian.com/uk-news/2020/jul/18/uk-plans-millions-of-coronavirus-antibody-tests-after-trial-success-report

No chance of a speeding ticket this time lol.

Becoming another great day at the office.

Lost count now the amount of wheeling and dealing I've done on this stock. Now nicely averaged down to 37. Got them all lined up now waiting for the storm to come.

https://www.bbc.co.uk/news/health-53467022

All the placing shares have now been issued. To think only last week this was placed at 35, our market cap has gone up 20m as well. Looking bullish now.

Looks like I made the right decision here.

Totally disagree, Synairgen has been working with the NHS since March now. 100 people in the hospital setting and 100 in the home setting, that is a lot of people dosed for a phase 2 trial. 79% success rate proves that this is a very effective treatment. In the presentation the CEO said (which many will be happy to hear) the problem they ran into during the trials, was that there were fewer Covid cases which mean the number of people infected with Covid had decreased. This is probably due to the social distancing and test & trace.

They can now start phase 3 trials in the countries that need it. I am sure SNG001 will now be quickly approved for global export by WHO to the counties that most need it. The orders will start coming in now.

SNG001 is so far imo the best treatment for CV19. The treatment seems far more safe than the vaccines they are rushing on to the market. A 79% success rate is impressive. SNG001 does not circulate through the body like a vaccine, it is delivered straight to the lungs via the inhaler, this means fewer side effects. It's got to be the inhaler for now until the vaccine is properly tested and approved.

We are starting to move North. Lovely jubbly.

15p? Great price, you'll be able to retire now lol. What a day.

Good to see you on here Woodsy. Didn't know you were invested here as well.

Make sure to hold back some for when the big orders start coming in, If USA, India, or Brazil start putting in orders this will rocket. SNG are the first to use the Interferon Beta with the inhaler method. I'm sure most would prefer the inhaler over the vaccine.

I posted this on Friday,

https://www.youtube.com/watch?v=npEFq4AiuIY

Results for the patients dosed in the Hospital setting is due anytime now. Don't forget, the drug has already been approved by MHRA, so production will be next.

Never in a million years did I think it would happen the next day. WOW.

Well done Synairgen.

Sold out most of my holdings today. Couldn't resist the multi-bagger. Kept some spare in case we see 3's and 4's. Good times.

Lol, they already know a presentation is available. Don't you read? This was known from the 10th July.

Fri, 10th Jul 2020 07:00

RNS Number : 5889S
Omega Diagnostics Group PLC
10 July 2020



OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")



Notice of Results

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that it will release its financial results for the year ended 31 March 2020 on Tuesday 14 July 2020.

Omega will be hosting a live online presentation open to all investors on Wednesday 15 July at 4.30pm, delivered by Colin King, CEO. The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management on its results whilst additionally providing an update on the business and current trading.

The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics plc via the following link:

https://investormeetcompany.com/omega-diagnostics-group-plc/register-investor.

For those investors who have already registered and added to meet the Company, they will automatically be invited

MB - they already made an announcement about that presentation last week. Seen that presentation numerous times now, they're over egging it. We need updates on the lateral flow devices, and how the tests are going.

Was a long time coming but SNG popped today, just like I thought they would. Fully expect Omega to do the same here very soon. What annoys me with Omega is the constant noise and ramping up like todays RNS. Totally pointless, and I'm sure this type of ramping up scares off investors, as they can see right through it. Lets have some news when it's significant please. Thanks and GL.

What a fantastic day. The patient have certainly taken from the impatient today. More thrills and spills to come I'm sure.

The Q&A presentation was very informative and interesting. Two questions stood out for me.

1. Do you think you will be able to get this drug to other countries with high death rates?
2. Interferon B is readily available around the world. Would this be just as effective if used as an injection?

1. Because of the positive data set released today, Synairgen are expecting a lot of international interest.
2. The inhaler enables Interferon B to be distributed at high strength directly to where all the action is, the lungs. An injection means the drug would have to circulate around the body and through the brain. By the time it gets to the lungs the strength of the drug would be diluted and less effective, not to mention the side effects that comes via injecting.

As far as I am aware Synairgen has patented the use of Interferon B via their inhaler, which is very significant. A very interesting presentation which is worth a watch if you haven't already.